Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.325p on 04-03-2026 at 17:30:09
Change 0.01p 3.17%
Buy 0.35p
Sell 0.30p
Last Trade: Sell 6,000.00 at 0.30p
Day's Volume: 1,168,922
Last Close: 0.325p
Open: 0.325p
ISIN: GB00BLH13C52
Day's Range 0.325p - 0.325p
52wk Range: 0.225p - 0.80p
Market Capitalisation: £2.41m
VWAP: 0.326962p
Shares in Issue: 742.80m

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 6,000 0.30p Ordinary
15:57:49 - 04-Mar-26
Buy* 428 0.35p Ordinary
15:17:37 - 04-Mar-26
Buy* 109,641 0.3348p Ordinary
15:04:23 - 04-Mar-26
Sell* 102,000 0.315p Ordinary
14:50:45 - 04-Mar-26
Buy* 297,494 0.3348p Ordinary
13:37:04 - 04-Mar-26
Sell* 5 0.3133p Ordinary
09:47:27 - 04-Mar-26
Buy* 57,626 0.335p Ordinary
08:59:24 - 04-Mar-26
Sell* 155,978 0.315p Ordinary
08:42:39 - 04-Mar-26
Buy* 116,817 0.339p Ordinary
08:42:27 - 04-Mar-26
Buy* 55,587 0.349p Ordinary
08:17:46 - 04-Mar-26
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Mar 2026 (Wed) 0.325 0.325 0.325 0.325 1,168,922
3rd Mar 2026 (Tue) 0.335 0.335 0.315 0.315 4,011,533
2nd Mar 2026 (Mon) 0.335 0.335 0.335 0.335 4,090,766
27th Feb 2026 (Fri) 0.33 0.33 0.33 0.33 2,189,299
26th Feb 2026 (Thu) 0.33 0.33 0.33 0.33 843,666
25th Feb 2026 (Wed) 0.33 0.33 0.33 0.33 6,083,325
24th Feb 2026 (Tue) 0.31 0.33 0.31 0.33 19,390,192
23rd Feb 2026 (Mon) 0.31 0.31 0.31 0.31 5,693,122
20th Feb 2026 (Fri) 0.32 0.32 0.31 0.31 3,871,609
19th Feb 2026 (Thu) 0.32 0.32 0.32 0.32 681,722
18th Feb 2026 (Wed) 0.305 0.32 0.305 0.32 4,464,515
17th Feb 2026 (Tue) 0.315 0.315 0.305 0.305 4,012,121
16th Feb 2026 (Mon) 0.315 0.315 0.315 0.315 898,064
13th Feb 2026 (Fri) 0.335 0.33 0.33 0.33 11,417,806
12th Feb 2026 (Thu) 0.335 0.335 0.335 0.335 1,274,356
11th Feb 2026 (Wed) 0.33 0.335 0.32 0.335 9,890,047
10th Feb 2026 (Tue) 0.345 0.345 0.33 0.33 2,354,286
9th Feb 2026 (Mon) 0.345 0.345 0.345 0.345 1,217,939
6th Feb 2026 (Fri) 0.345 0.345 0.345 0.345 478,621
5th Feb 2026 (Thu) 0.355 0.355 0.345 0.345 1,176,301
4th Feb 2026 (Wed) 0.35 0.355 0.35 0.35 869,219
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
2nd Mar 2026 7:00 am RNS ValiRx forms ValiRx Animal Health Ltd subsidiary
19th Jan 2026 7:00 am RNS Exercise of Warrants
9th Jan 2026 3:45 pm RNS Replacement: Evaluation and Transfer Agreement
9th Jan 2026 7:00 am RNS New Evaluation and Material Transfer Agreement
8th Jan 2026 1:00 pm RNS Holding(s) in Company
5th Dec 2025 10:56 am RNS Holding(s) in Company
24th Nov 2025 3:54 pm RNS Holding(s) in Company
24th Nov 2025 9:30 am RNS Holding(s) in Company
20th Nov 2025 12:11 pm RNS Result of GM & Issue of Equity
13th Nov 2025 2:16 pm RNS Holding(s) in Company
See more ValiRx regulatory news

ValiRx (VAL) Share News

IN BRIEF: ValiRx establishes veterinary oncology-focused subsidiary

3rd Mar 2026 04:05

ValiRx PLC - London-based life science company - Establishes wholly owned subsidiary ValiRx Animal Health Ltd to develop and commercialise its oncology assets in the veterinary market. The subsidiary will use preclinical work from ValiRx human programmes to pursue comparative oncology opportunities. "There is a strong scientific rationale, as well as market opportunities, for this ethical approach and several examples of companies that have followed this route," says Chief Executive Officer Mark Eccleston, who adds that the three key areas of focus will be Osteosarcoma, Lymphoma and Hemangiosarcoma. ValiRx said specialist veterinary venture capitalist funds have been identified and approached with the intention that the subsidiary will be independently funded. The global veterinary oncology market was valued at USD1.58 billion in 2024 and is projected to reach USD4.86 billion by 2034, representing a compound annual growth rate of 12%. Read More

TRADING UPDATES: Life Science REIT portfolio valuation declines 7.8%

9th Jan 2026 19:14

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Unilever targets early December Ice Cream spin-off

4th Nov 2025 20:07

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Getech hails contracts; Rome Resources plunges

30th Oct 2025 11:18

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

LONDON MARKET OPEN: Stocks fall after Fed casts doubt on December cut

30th Oct 2025 09:16

(Alliance News) - Stock prices in London opened lower on Thursday, as the FTSE 100 retreated from a record high in the wake of a "hawkish" cut by the Federal Reserve. Read More

See more ValiRx news
FTSE 100 Latest
Value10,567.65
Change83.52

Login to your account

Forgot Password?

Not Registered